
11:48 ET Notice of QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

I'm PortAI, I can summarize articles.
Kessler Topaz Meltzer & Check, LLP is investigating potential federal securities law violations on behalf of investors in uniQure N.V. (NASDAQ: QURE). Following a press release on November 3, 2025, uniQure's stock plummeted over 50% after the FDA indicated that data for its AMT-130 gene therapy was insufficient for a Biologics License Application. Investors with significant losses are encouraged to contact the firm for more information.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

